Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (3)
- (-) Coronavirus (3)
- 3-D Printing/Advanced Manufacturing (2)
- Bioenergy (3)
- Climate Change (1)
- Composites (1)
- Computer Science (4)
- Environment (2)
- Materials Science (6)
- Microscopy (1)
- Nanotechnology (4)
- National Security (1)
- Neutron Science (21)
- Physics (4)
- Quantum Science (2)
- Summit (4)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.